Keywords: strong, safety, efficacy, data, chimerivax-je, cambridge, uk-based

Strong safety and efficacy data for ChimeriVax-JE

Article | 06 November 2006

Cambridge, UK-based Acambis has reported positive results from a pivotal Phase III safety trial of ChimeriVax-JE, its investigational single-dose vaccine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Japanese Encephalitis Virus Vaccine Inactivated

Je-Vax

Go to drug listing